Mavacoxib
 | |
| Clinical data | |
|---|---|
| Trade names | Trocoxil |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| 170569-88-7 | |
| QM01AH92 | |
| PubChem | CID 9843089 |
| ChemSpider | 8018804 |
| UNII | YFT7X7SR77 |
| ChEBI | CHEBI:76207 |
| Chemical data | |
| Formula | C16H11F4N3O2S |
| 385 g/mol | |
|
SMILES
| |
| |
Mavacoxib (trade name Trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease.[1] It acts as a COX-2 inhibitor.[2]
References
- ↑ European Public Assessment Report (EPAR): Trocoxil, European Medicines Agency
- ↑ Cox, S. R.; Lesman, S. P.; Boucher, J. F.; Krautmann, M. J.; Hummel, B. D.; Savides, M.; Marsh, S.; Fielder, A.; Stegemann, M. R. (2010). "The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs". Journal of Veterinary Pharmacology and Therapeutics 33 (5): 461–70. doi:10.1111/j.1365-2885.2010.01165.x. PMID 20840390.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||